Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

Per donar una segona vida als acumuladors de fred que s'usen als laboratoris clínics, després d’higienitzar-los estan disponibles per a totes les unitats assistencials per ser usats amb pacients.

These studies, part of the BEACON project, describe the efficacy of a new immunotherapy treatment for neuroblastoma and the usefulness of new biomarkers in predicting the prognosis and response to therapy.

HIV infected cells expressing the CD32 molecule are more resistant to the action of the natural killer cells of the immune system, which are key in the fight against viral infections.

The work was one of the first to identify skin lesions associated with SARS-CoV-2 infection in children at the beginning of the pandemic.

Aquest matí, pacients i professionals han escrit missatges amb raons per no fumar en dos plafons dissenyats per a l'ocasió i han obtingut obsequis a canvi.

28 talented young people have presented their proposals for the metropolis' future after a 9-month immersion in its power structures under the guidance of Barcelona Global.

The research aims to identify which patients with isolated radiological syndrome are more likely to develop the disease.

Durant el mes de juny, organitzem tres activitats sobre assaigs clínics, genètica i imatges científiques.

L’Hospital Universitari Vall d’Hebron acull en el Cemcat l’atenció al pacient amb esclerosi múltiple, convertint-se en un hospital capdavanter en el diagnòstic i tractament d’aquesta patologia.

El director del programa ECMO de Vall d’Hebron va participar en la darrera edició del congrés EuroELSO, que va celebrar-se a Londres aquest mes de maig.

The study showing how thrombocytopenia increases the risk of thrombosis in patients with antiphospholipid syndrome has been considered the best paper published in 2021.

Aquesta trobada es dirigeix a un públic de totes les edats amb un ampli ventall de formats: experiments, instal·lacions, jocs, tallers, demostracions, espectacles, debats, microxerrades, itineraris i visites guiades, entre d’altres.

The identification of genetic alterations is key to be able to administer targeted therapies to each patient.

EXIMIOUS is a project funded by the Horizon 2020 program that aims to study the exposome to understand its relationship with immune-mediated diseases.

EU-PEARL hopes to transform standard clinical trials into collaborative multi-compound research platforms focused on patients.

Un total de 2.873 pacients van participar en els assaigs clínics que Vall d’Hebron va fer l’any 2021, un any en què es van posar en marxa 443 assaigs nous. 

The head of the Medical Molecular Imaging group at VHIR received the recognition for the best poster presentation for a study on myocardial insulin resistance and cardiovascular risk.

For two days, 30 people between Hepatologia¡ unit researchers and industry experts have laid the foundations for this project.

BSC coordinates QUSTom, the first project that will use supercomputing to detect tumors more effectively and safely.

VHIR collaborates with Nanbiosis through the FVPR service platform created within the Drug Delivery and Targeting Research Group (DTT).

H2O és el primer projecte en l’àmbit europeu a gran escala que recopilarà i incorporarà els resultats dels i de les pacients de manera sistemàtica en la presa de decisions d'atenció mèdica.

En el Dia Internacional de la Infermeria fem valdre la figura del professional de la infermeria especialitzat, amb capacitat per prendre decisions complexes i formació per exercir la docència, la recerca i millorar la seguretat del pacient.

Researchers at Vall d'Hebron have established a simple algorithm of recommendations for taking the arterial pulse, a rapid and non-invasive method for identifying patients with atrial fibrillation, a type of arrhythmia that increases the risk of stroke.